DrugDashboards

Tension Headache Relief

Acetaminophen-Caffeine · ACETAMINOPHEN 500 mg/1; CAFFEINE 65 mg/1 · Tablet, Coated · Oral · Target Corporation

NDC 11673-0839-01 · 100 TABLET, COATED in 1 CARTON · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for acetaminophen, caffeine (oral solid) in the next 90 days

sole-source market · price up 8% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
M013
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Acetaminophen-Caffeine (Tablet, Coated)

LabelerStrengthFirst seenLast seen
Target CorporationACETAMINOPHEN 500 mg/1; CAFFEINE 65 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tension Headache Relief — NDC 11673-0839-01," retrieved September 3, 2026, https://drugdashboards.com/drug/11673083901.

Free to cite with attribution — see how the data is put together.